Cargando…
Decision Science Can Inform Clinical Trade-Offs Regarding Cardiotoxic Cancer Treatments
Cancer treatment-related cardiotoxicity (ie, heart failure, coronary artery disease, vascular diseases, arrhythmia) is a growing cancer survivorship concern within oncology practice; heart disease is the leading cause of noncancer death in cancer survivors and surpasses cancer as the leading cause o...
Autores principales: | Gillman, Arielle S, Vo, Jacqueline B, Nohria, Anju, Ferrer, Rebecca A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328021/ https://www.ncbi.nlm.nih.gov/pubmed/34350379 http://dx.doi.org/10.1093/jncics/pkab053 |
Ejemplares similares
-
Anthracycline Cardiotoxicity: Can CT Move Us Further?
por: Campia, Umberto, et al.
Publicado: (2020) -
Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis
por: Obasi, Mary, et al.
Publicado: (2021) -
How to Diagnose and Manage Radiation Cardiotoxicity
por: Ganatra, Sarju, et al.
Publicado: (2020) -
The superior explanatory power of models that admit trade-offs in moral judgment and decision-making
por: Lieberman, Debra, et al.
Publicado: (2022) -
Trade-offs in cavefish sensory capacity
por: Gunter, Helen, et al.
Publicado: (2013)